Search

Displaying results 7851 - 7860 of 10000 in total
  1. Drug

    Carisbamate

    go.drugbank.com/drugs/DB12338
    Investigational

    Carisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence.

  2. Drug

    Rostafuroxin

    go.drugbank.com/drugs/DB12350
    Investigational

    Rostafuroxin has been used in trials studying the treatment of Essential Hypertension.

  3. Drug

    Razupenem

    go.drugbank.com/drugs/DB12587
    Investigational

    Razupenem has been used in trials studying the treatment of Skin Infections.

  4. Drug

    PF-477736

    go.drugbank.com/drugs/DB12611
    Investigational

    PF-00477736 has been used in trials studying the treatment of Neoplasms.

  5. Drug

    CE-326597

    go.drugbank.com/drugs/DB12694
    Investigational

    CE-326,597 has been used in trials studying the treatment of Obesity.

  6. Drug

    Acediasulfone

    go.drugbank.com/drugs/DB08926
    Experimental

    Acediasulfone (INN) is an antimicrobial and antimalarial long-acting prodrug of dapsone.

  7. Drug

    Gancotamab

    go.drugbank.com/drugs/DB14784
    Investigational

    Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. … Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients).

  8. Drug

    Nerofe

    go.drugbank.com/drugs/DB14786
    Investigational

    Nerofe is under investigation in clinical trial NCT03059615 (A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS).

  9. Drug

    Xentuzumab

    go.drugbank.com/drugs/DB14871
    Investigational

    Xentuzumab is under investigation in clinical trial NCT02191891 (Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC))

  10. Drug

    Ladostigil

    go.drugbank.com/drugs/DB16213
    Investigational

    Ladostigil is under investigation in clinical trial NCT01429623 (A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment).